The Obesity Drug Revolution: How Medicare Coverage and Trump’s Plan Could Reshape the Market The landscape of obesity treatment is poised for a dramatic shift. Eli Lilly CEO Dave Ricks recently signaled that upcoming Medicare coverage, coupled with pricing agreements struck with the Trump administration, could be a game-changer for the rollout of their experimental … Read more
The AI Reckoning: Why Software Stocks Are Facing a Turbulent Future The recent sell-off in software stocks isn’t just a market correction; it’s a fundamental reassessment of value in the age of artificial intelligence. Investors are waking up to the possibility that the decades-long reign of predictable software revenue growth may be coming to an … Read more
President Donald Trump announced Monday a new round of tariffs on goods imported from South Korea, increasing duties on autos, pharmaceuticals, and lumber from 15% to 25%. The action comes in response to a delay in the South Korean legislature’s approval of a trade deal initially reached with the United States last summer. Tariff Increase … Read more
The Shifting Sands of Pharma: Navigating Patent Cliffs, Deals, and a New Political Landscape The pharmaceutical industry entered 2026 with a cautious optimism, a sentiment echoing from the recent JPMorgan Healthcare Conference in San Francisco. While geopolitical uncertainties lingered in 2025, a potential turning point for the sector is on the horizon, fueled by falling … Read more
Stellantis at a Crossroads: Can a New CEO Revive a Troubled Merger? Five years after the formation of Stellantis, the automotive giant born from the merger of Fiat Chrysler and Groupe PSA, the initial promise of synergy and growth remains largely unfulfilled. Shares have underperformed, and a recent shift in leadership signals a critical turning … Read more
The Buffett Succession: Will Greg Abel Spend Berkshire’s $381 Billion? Warren Buffett’s recent handover of the CEO role at Berkshire Hathaway to Greg Abel marks not just a changing of the guard, but a pivotal moment for one of the world’s most closely watched companies. With a record $381.6 billion in cash, Berkshire is facing … Read more
Costco’s Comeback: Is the Warehouse Giant Back on Top? After a sluggish 2025, Costco is signaling a strong resurgence. A recent surge in December sales – up 6.3% in U.S. comparable sales – has ignited investor confidence and prompted analysts to reassess their outlook. This isn’t just a blip; it suggests Costco is addressing concerns … Read more
The Streaming Wars Heat Up: Warner Bros. Discovery, Paramount, and Netflix Battle for Dominance The ongoing saga of Warner Bros. Discovery (WBD) has become a focal point in the rapidly evolving media landscape. The latest development – WBD’s board unanimously rejecting Paramount Skydance’s hostile takeover bid in favor of a deal with Netflix – isn’t … Read more
The $300 Billion Question: What’s Next for Berkshire Hathaway’s Stock Portfolio? Warren Buffett’s official retirement as CEO of Berkshire Hathaway marks not an end, but a transition. While Greg Abel steps into the top role, a significant question looms over the conglomerate: what will become of its massive, $300 billion equity portfolio? For decades, this … Read more
The Rise of the AI Shopping Assistant: How Agentic Commerce Will Reshape Retail Forget endlessly scrolling through websites. The future of shopping isn’t about *you* finding products; it’s about products finding *you* – or rather, an AI agent finding them for you. This emerging trend, dubbed “agentic commerce,” is poised to revolutionize how we buy … Read more